Other Non-Current Liabilities
ResMed Other Non-Current Liabilities increased by 5.4% to $146.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 198.2%, from $48.98M to $146.08M. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 113.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.80M | $5.98M | $6.35M | $5.10M | $5.97M | $5.84M | $50.60M | $69.55M | $68.17M | $34.33M | $72.89M | $47.55M | $42.26M | $83.27M | $10.83M | $48.98M | $141.52M | $138.18M | $138.54M | $146.08M |
| QoQ Change | — | -12.1% | +6.2% | -19.6% | +17.1% | -2.3% | +766.8% | +37.4% | -2.0% | -49.6% | +112.3% | -34.8% | -11.1% | +97.1% | -87.0% | +352.2% | +188.9% | -2.4% | +0.3% | +5.4% |
| YoY Change | — | — | — | — | -12.2% | -2.4% | +696.9% | >999% | >999% | +488.0% | +44.1% | -31.6% | -38.0% | +142.6% | -85.1% | +3.0% | +234.9% | +65.9% | >999% | +198.2% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is ResMed's other non-current liabilities?
- ResMed (RMD) reported other non-current liabilities of $146.08M in Q1 2026.
- How has ResMed's other non-current liabilities changed year-over-year?
- ResMed's other non-current liabilities increased by 198.2% year-over-year, from $48.98M to $146.08M.
- What is the long-term trend for ResMed's other non-current liabilities?
- Over 4 years (2021 to 2025), ResMed's other non-current liabilities has grown at a 113.6% compound annual growth rate (CAGR), from $6.80M to $141.52M.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.